共 50 条
- [41] Response evaluation of neo-adjuvant chemotherapy by Tc-99m sestamibi in locally advanced breast cancer patients: An effective modality [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
- [42] Prediction and assessment of response to neo-adjuvant chemotherapy in breast cancer: The responsibilities of breast pathologists [J]. BREAST JOURNAL, 2021, 27 (08): : 629 - 630
- [43] Homologous recombination deficiency in breast cancer and association with response to neo-adjuvant chemotherapy [J]. EJC SUPPLEMENTS, 2010, 8 (03): : 60 - 61
- [45] Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy [J]. Breast Cancer Research and Treatment, 2020, 184 : 433 - 444
- [46] Elevated Neutrophil–Lymphocyte Ratio in Luminal-Type Locally Advanced Breast Cancer to Circumvent Neo-Adjuvant Chemotherapy [J]. Indian Journal of Surgical Oncology, 2019, 10 : 454 - 459
- [47] Loco-regional Control After Neo-Adjuvant Chemotherapy and Conservative Treatment for Locally Advanced Breast Cancer Patients [J]. BREAST DISEASES, 2015, 26 (01): : 65 - 67
- [48] Loco-regional Control After Neo-adjuvant Chemotherapy and Conservative Treatment for Locally Advanced Breast Cancer Patients [J]. BREAST JOURNAL, 2014, 20 (04): : 381 - 387
- [49] Pathologic response and residual tumor cellularity after neo-adjuvant chemotherapy predict prognosis in breast cancer patients [J]. BREAST, 2023, 69 : 323 - 329